Trial NCT00572182

View at ClinicalTrials.gov 
Aliases: NCT00923208
Org. Study IDs: CDR0000578114
Secondary IDs: NCI-09-C-0112 PBTC-024 U01CA081457

Last trial update was posted on 2012-03-06

MeSH Interventions

3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid

MeSH Conditions

Central Nervous System Neoplasms Nervous System Neoplasms

Other Conditions

Brain and Central Nervous System Tumors

Stopping Reasons

This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID